Montag & Associates’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3
| Closed | – | – | 957 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 872 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 832 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 852 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 864 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 871 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 864 |
|
|
2021
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 867 |
|